Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2000 | 03-1999 | |
| Sales | 10 | 150 |
| Gross Profit | 10 | 150 |
| Operating Expenses | 3,060 | 1,940 |
| Operating Income | -3,049 | -1,790 |
| Interest Expense | 138 | 7 |
| Other Income | 211 | 137 |
| Pre-tax Income | -2,976 | -1,660 |
| Net Income Continuous | -2,976 | -1,660 |
| Net Income | $-2,976 | $-1,660 |
| EPS Basic Total Ops | -0.35 | N/A |
| EPS Basic Continuous Ops | -0.36 | N/A |
| EPS Diluted Total Ops | -0.35 | N/A |
| EPS Diluted Continuous Ops | -0.36 | N/A |
| EBITDA(a) | $-2,963 | $-1,740 |